林晨晖
2022-07-13

$Novavax(NVAX)$with all the delays the FDA approval isn’t reflected in price yet.

We can see before people fall for shorts and bears traps, do not sell your shares with or without news today.

The news will come and a lot of more good news to. Do not forget all the countries that already approved the vaccine should start rising their orders because covid impact in health systems is rising and so the pressure to get a new vaccine is greater than ever before.

It will rise stock price of $128 end of August 2022.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment